INFLUENCE
States
OF TIME,
TEMPERATURE
AND
CONCENTRAT I ON ON DOG PLATELET
D.
Brackett, C. F.
J.
Department Health
8, PP. 441-451, Pergamon Press,
Vol.
THROMBOSIS RESEARCH Printed in the United
of
Sciences
and
University
Center,
PLATELET
AGGREGAT I ON
Schaefer
Medicine,
1976
Inc.
Oklahoma
C.
G.
of
Oklahoma
City,
Gunn
Ok.
73190
(Received 23.12.1975; in revised form 7.2.1976. Accepted by Editor P.M. Mannucci)
ABSTRACT Previously in
encountered
laboratory
physical
and
factors
canine
variability
clinical that
platelets).
various
affect Valid
conditions
of
this
technique
tration 90
and
min
stable, in
ed
the
not
by
Choice
amplitude 21
after
temperatures. aggregation though,
platelet was
in rich
stronger
after
Comparing response
that
of
hr) by
30
short
term
freezing
at or
agents, significantly
equal weights of the resulting molar ADP
(30 uM EPI
vs
concen-
For the aggregation
first was
after
temperature
two affectwas
temperature
(37OC and 40°C)
average greater
amplitude than to
agents per volume concentration of
21
but
(EPI),
aggregation
room
body
the
Using
platelet
uM epinephrine
storage
the the
below.
EPI-induced
(OOC)
under
occurred
storage
(ADP).
aggregating to ADP was
in administering plasma (PRP),
platelet
common
calibrating
between
aggregability
induced
at
by
response. of
(one
diphosphate
storage
than
platelet
short-term
aggregation
greater
than
even
of
uM adenosine
significantly (20°C)
in of
found
of
(specifically,
described
aggregation
magnitude
study
responses
possible
method
was
responses
this
platelets
platelet
made
the
the
the
deterioration
vitro.
using
of
of
of
was
relationship
amplitude
venepuncture,
but
hr
a direct
after
study
aggregation
prompted
comparison
system
the
platelet
aggregability
this
aggregometer-recorder
in
investigations
of EPI of EPI
uM ADP).
INTRODUCTION
ometry to
The in vitro measurement of platelet (1) is enjoying an expanding usage.
clinical
logical
and and
experimental
biochemical
hematology
factors
In experimental genetically determined
hematology, bleeding
Very
about
little
is
known
canine
which
aggregation
in
increase
the dog disorders platelets 441
by
continuous
This technique is of the study of physical, or
decrease
is a useful (2,3,) and beyond
platelet
model for coagulation
their
reduced
turbidgreat value physioaggregation.
the study of mechanisms reactivity
(4).
443
ON DOG
when
compared
platelet rich
with
plasma
ability
present As
and
serious
of
this
study
are
from
venepuncture
fully
physical
in
(8),
Gaetano
be
used
factors
as
istered
de
for
equal
From If
needle. the of
the
sample
syringe ferral tube
blood or
to
cuvette.
All
placed
in
filled
directly
the
and
aggregometer. from
Centrifugation plasma the
amount
observed visibly When
of at
this
PRP
point
blood
whole
3500
blood in
RPM to
and
at
37°C
Since
by there
were
marked
from
G) the
epinephrine ml).
from
differences
or
allowed
produce
time
admin-
was
gently
stoppers
were
for
by
covered
used
blood
a
ratio
tilting.
plasma
with
the
the in
down
or
vein
blood, from
streaming
whole
limb clear
(.13M)
mixed
blood
always
a
to
free-flowing
immediately
for
in
10 min
highest
to
Trans-
the
side
was
freshly
cover
platelet
of
the
parafilm
produced
platelet
centrifuged the
point
plasma rich
at at
until
counts
were
water
in
1% ammonium No.
bath
the
red
G)
and
cells
had
coat had formed. removed using a except
method collected
oxalate The
poor for
when
of
the
effects
Brecher in self-
and
contained in amount and extent
in plasma turbidity was measured Aggregometer coupled to a chart While in the aggregometer, the a Teflon coated stir bar and was
heating in
5855).
platelet possible
825 RPM (55
which
and a buffy plasma was
a 37oC
the
yield
using the phase contrast for platelet counts was
temperature
(EPI),
a jugular
were
with
was
and kept studied.
diluted
2)
storage temperature. studied using two
needle.
(986 get
concentration,
citrate
(Becton-Dickinson,
a constant
of
aggregation
standardization have evolved
transferred
of platelet aggregation reflected by a change photometrically using a Chronolog 300 Platelet recorder (Texas instruments Servo-Riter I I). plasma was constantly stirred at 1200 RPM by held
7)
3.8% sodium
pipettes
amount of the platelet
were made or plasma
tubes
platelet
contact
Teflon
blood
reservoirs
platelet
This variwhich prompted
platelet
the that
careful
were
determine
reached,
and
by
cuvettes
to
was
dog
of
independent
of
blood
and
Adams).
the
required
I)
drawn
done
intervals
the
of
PRP.
6,
also
3) short-term factors was
of
was
always
The
attempt
same
calibration
immediately
required,
counts Blood
capillary
polyethylene
not
intravenous
Pasteur pipette temperature were
Platelet Cronkite (9). filling
an
2 min
cleared
siliconized of storage
at In
(PPP).
the
was drops
glassware the
samples
METHODS
containing
was
Clay
times,
AND
blood
did
9 parts
plasma
all
of
The
or
of
method preparation
and three
these
several
tube
(Siliclad,
at
ml
discarded.
(See
diphosphate (ADP) and volume of PRP (5 ug/O.5
after
a siliconized
siliconized tubes
30
the
comparability
were
test,
by
venepuncture
citrate
of
the
was
to
1 part
dogs
syringes
on
a method
investigated
aggregation
adenosine weights per
fasting
plastic
serial
aggregation.
valid
MATERIALS
into
observations in
below.
influenced
agents,
preliminary
questions
platelet
described
to
Aggregability ing
Our
variability
determinations
of
VoL.S,No.4
AGGREGATION
The aggregometer calibration blood handling and platelet
techniques
aggregat
multiple
study
must
measurements.
(5). marked
methodological
by
variation
The
in
parametric
suggested
sample
species
disclosed
(PRP)
raised
the
other
aggregation
PLATELET
device. the
photodensities
of
the
sil
iconized
04 DOG
cuvettes,
they
cuvette’s
orientation
Before the
optical 100
of water The
scale.
Changes
in
PRP baseline
b)
platelet
The
gently was
density amount
being been
the
and
or
then
recorded
tilting in
to
stabilize
in
this
each
trial
This
to
optical
by
between
density
of
the
a cuvette
of the recorder set at its to the 10 mv scale for the
the
in The
density
time
the
tube
the
aggregometer,
of 30
were
aggregometer.
in
difference
at the calibration
for
(expressed
optical
(the
of and
0.4
ml
and the
set,
millivolts critical
between optical
was
to the method.
pipetted
after
baseline
challenged At
of deflecreadings of
PRP and density
peak response the recording
PRP,
determine
if
consists
of
modification of
of
any
the PPP) between
and PRP
aggregating
into
the
optical
was
recorded
a cuvette. density
of
for
with the aggregating this time the temperature
spontaneous
platelet
PPP
5 separate of
count
from
the
the
on
same
series
above
the
1 min.
agent of
90 set 37’C
to
Duplicate
counts
were
the
accuracy
dilutions
The
final
To
of
Samples
increase
less
than
EPI
from
di lution
were
of
of
each
had
a final
at
of
ADP
each
of
or
the
twice
and
5 ug
storaqe 1 hr at EPI
these
were
used
were established The plasma used
the
Relationship quots of
the
by dividing to obtain from
of platelet PRP were tested
on
usual
each
of
30
test
of the
amount
of
varying
dilutions
the
platelet
means
platelet
by
the
with
platelet
were
aggregated in
diluted
and
the
counts
ADP
to
requiring
of
these
counts
from
PRP
PRP was
added
to
4
halved.
5 ug
cuvette
of of
either
ADP
PRP was
21
or
EPI.
uM while
uM. on platelet of O°C, 20°C, platelet
aqqreqation. 37OC, or
aggregation
in
4O’C.
Al iquots Five
PRP samples
temperatures. parameters procedure
derived
of
the
temperatures temperatures
Effects of centrifuqation of a standard centrifugation
was
in
each
5 different observers
subsequent
concentration
Influence of short-term of PRP were stored for amounts
70%,
reservoir
concentrations
of
occurred
experiments,
counts
trained
diluting
had
PRP was
produce
two
used.
of
PRP photodensity.
blood
71%, 56%, 45%, and 36%). “bl ind” by were done
the
shift
of were and
method.
(lOO%, dilutions
ment
calibrated
system.
study
Influence amounts
ug
was
difference
by the PRP from all storage temperatures. The aggregating in 0.1 ml of isotonic saline was streamed down the side EPI) into the PRP. The changes in photodensity during aggregation PPP base1 ines were recorded before for 5 min (See Fig. 1).
follmting
stored
the
aggregation.
in
study
in
aggregometer-recorder
5 ug
the
each
reached
after
with
that
system until
chart range turned up
PRP
platelet
response
placed
agent (ADP the cuvette
the
of
of
difference
placed
allowed
ink
so
same.
measurements.
PRP samples
after had
the full was then
and the same plasma were based upon this
PRP was All
black
(the
After
marked
the
aggregometer
to
aggregation
cuvette
and
always
aggregometer-recorder the
of
the
a)
density
a cuvette
optical
reflected
baseline agent)
the of
Ic’c3
AGGREGXTIOX
was
was equal amplification
aggregation
tion)
optical
photocell
experiment,
density mv
for the
amplification
distilled
platelet
matched to
each
adjusting of
were
PLATELET
blood
on
platelet yield. To test the reliability for obtaining PRP from dog blood, ratios
PRP platelet PRP platelet centrifuged
response to for platelet
counts count at
825
time elapsed aggregation
by whole for the RPM
(55
from with
G)
blood ratio for
blood 5 ug
platelet in each
counts. experi-
8 min. collection. of ADP and
Ali5 ug of
iii
04 DOG PLATELET
after the PRP and of blood collection.
EPI immediately hours from time ADP
dose-response
Immediately with
1.0
phasic
ug
(4
curve,
the
standard
ADP
dose
curve
threshold
after
uM ADP)
a
function
of
were
PPP were
of
PRP and
added
to
aliquots
portending
maximum response
for
the
until
the
amount
was
adjusted If
found.
the
aggregation,
standard
curve
prepared
time
PPP,
aggregation
level
was
as
preparation
the
AGGREGA,TIOX
from
I
I
0
I
I
5
collection.
used
not
obtained.
Thi_s
At
achieved the 4 hr
was
10 min
to
I
I
for
was
sufficient
2
I
blood
hour
starting mono-
experiment.
was
each
increasing doses of ADP of PRP until a fast-rising
duced to determine the lowest dose of ADP yielding determinations were carried out for approximately
1
and
intervals
produce
the
the
next
as the
standard
dose
was
re-
standard curve. These after blood collection.
I
I
3
I
I
4
J
5
MINUTES
FIG. Aggregation
responses
diphosphate ing agents curves The from
(ADP) and in PRP was
were
aligned
amplitude baseline
following
of
of
at
the
to
(EPI). ADP and
point
(0
aggregation
density
1
platelets
epinephrine 21 uM for
platelet
(PRP
dog
prior
equal weights (5 ug) of adenosine The final concentration of aggregatThe two super imposed 30 uM for EPI.
min) was
to
0 min)
where
ADP
measured to
curve
or
EPI
in
millivolts
peak
was (most
added of
to
the
extreme
reading
0 min).
RESULTS
Correlation platelet
of platelet concentration
count with in platelet
PRP baseline rich plasma
photodensity was reflected
PRP.
deflection
levels. The in photodensito-
ON DOG
metric
and
statistical
IO
experiments,
count
across
factor
(10)
which
was
the all
used
otherwise
AGGREG_ATION
partial
correlation
5 PRP dilutions to
partial
would
have
of
was
out
the
PRP photo-
0.65
(P
influence
spuriously
c.01). of
inflated
this
This
the
PRP
and
follow-
correlations. The
to
platelet technique
dilution ing
In
baselines.
density
PLXTELET
be
PRP baselines
2 groups
of
The
identical. across
influence of tion response
all platelet with
was
number increasing
(P
aggregation
amp1 itude
< .Ol)
aggregation
produced
2 al iquots
by
significantly
of with
induced
used
the
with
ADP
baseline
and
EPI
were
found
photodensities
for
the
0.98.
analysis
more
be
of
The
on aqqreqation. PRP concentration
produced was
to
correlation
dilutions
significant whether
the
partial
by
variance or
aggregation
in EPI.
(P
increases
2)
(11).
increases ADP
1 inear
(Fig.
The
platelet However,
e.02)
than
in
were
found
mean
increase
numbers
5 ug of did
5 ug
aggrega-
to
in
was
the
ADP of
be same
(21
EPI
uM) (30
uM)..
OA DP(5yg)
4.0
3.0
2.0
1.0
..
0
40 PRP
The
influence
of
platelet
Each point represents and epinephrine as line
to
Influence Similar over
the
peak
of platelet fluctuations course
age amplitude of response to 5 ug response induced
of
FIG. plasma
rich
in
millivolts.
rich plasma in platelet 5 hr
from
80
100
CONCENTRATION
the average the aggregating
response
60
the
2 concentration
(%I
on
the
aggregation
of 10 experiments using adenosine agents. Aggregation was measured The bars indicate S.E.M.
storaqe aggregation time
of
time blood
on aqqreqation occurred for both co1 lection
(Fig.
response. diphasphate from
responses. ADP and 3).
EPI
The
platelet aggregation was consistently greater (P c.01) the aggregat Furthermore, of ADP than to 5 ug of EPI . by either ADP or EPI decreased with time elapsed from
PRP base
aver-
in ion blood
OS DOG
col
lect
ion,
although
collection significant
groups
results
were
data
at
at
4
5 hr
analyzed
in hr
C.01)
c.05)
for
Dunnett’s
collection
occurred
aggregability
(P
(P
using
from
AGGREGATIOZ
recovery
decline
2 and
and
I hr
at
transient
This
only
treated the
a
time.
PLATELET
t
found
after
blood
the
ADP-treated for
as
the
3 hr from
approximately was
Test
serving
k-01.8,so.G
to
be
statistically
collection
for
EPI-
groups.
These last Comparisons (11) with
Planned comparison
standard.
I 5.0
4.0
_
3.0
2.0
1
1.0
(5pq) (5JJg)
OADP .EPI
1
I
I
0
60
I
120
I
I
180
240
300
MINUTES FIG. Influence sponse of
to
elapsed
time
adenosine
term
The
storaqe
a definite
more responses
ADP
dose-related
Fig. the
5 demonstrates time of collection.
necessary
to
on
when storage
Furthermore, able. ADP produced reliably
constant (1 .O t ion. Within
bars
or
on
indicate
influence
on
aggregation
5 ug of each of PRP for
aggregating 1 hr at room
as
These a maximal
ug or 4-12 - 3.0 the period from
a
function in
point
aqqreqation.
EPI-induced
change
average
Each
aggregation
re-
respresents
a mean
S.E.M.
after 1 hr storage greater aggregation
the
the
epinephrine.
aggregation than after after storage at O°C,
threshold
produce
3
venepuncture
temperature
effect
induced aggregation With epinephrine, in significantly the platelet
after
diphosphate
9 experiments.
Short had
of
platelet
at
and
Storage no
effect
agent was temperature
temperature on
the
ADP-
used (Fig. 4). (20°C) resulted
storage at 37OC (P c .05), while 37oC, and 40°C were undifferenti-
all temperatures responses than of
time
after
sensitivity
data demonstrate and monophasic until uM ADP) 100 to 200 min
did blood over
that the aggregation approximately after blood
but 20°C, 5 ug of
5 ug of EPI.
collection. a 4
smallest curve
hr
period
from
dose of ADP is relatively
90 min collection,
from collectwo to
OS DOG
L-Ol.S,SO.ir
ten
fold
increases
platelet to
in the It is
response.
produce
maximum
‘3 E
5.0 I-
began
to
to produce the the dose of ADP to baseline after
decrease
IADP
(sing)
mEPI
(Spd
r
W
4.0
::
maximal sufficient 200 min.
I
u) ;
AGGREGATIOS
dose of ADP were required interesting to note that
aggregation
Y
iii
PLATELET
3.0
z 0
;
2.0 I-
a 0 ;
I.0 I
-
W W a
0
STORAGE
TEMPERATURE
4
FIG. Mean
amplitude
of
four
temperatures
sine
diphosphate
of
yield
for or The
9 experiments.
Platelet in platelet
aggregation
storage of platelet PRP was aggregated with
hour.
epinephrine.
Each
bars
S.E.M.
(55
ranged from from 1.3 to
centrifuged
one
indicate
as a function of numbers was observed
centrifugation
counts ranged
after
G for
0.7 2.2)
repeatedly
bar
represents
8 min).
The
Less when
2 min
ratios
of
variability blood
periods
at
PRP in
from
rich plasma at 5 ug of either
the
centrifuqation parameters. in 10 experiments when
to 2.6. occurred for
rc)
55 G until
response
High using to
the
these
mean
whole
1 ity
parameters
blood
platelet the
in
variabi
fixed
same
one of adeno-
platelet
counts
(ratios
10 experiments PRP yield
was
was
ade-
(18),
time
quate.
DISCUSSION
In
vitro
from physical (Figs.
time.
venepuncture variable 3 and 5).
As
previously to
influencing The
observed
aggregation pH of
in
test
(in
platelet plasma
man
(12,13)
vitro
time)
aggregation has
been
shown
and
in
was
a
rabbit highly
determinations to
cause
variability
important in.dogs in
ON
4is
platelet
aggregation
enhances
platelet
To
minimize
by
keeping
I vessels
it
changing
aggregation
cannot
nature
of
The min
this
the
CO2
an
increase,
completely
response
in
a
rising
pH of contact
pH which
8.0
with
S i nce the pH of out as a contributing
ruled
curves,
results
extensive
(Fig.
\‘01.8,?io.4
aphysiological
(16,17).
responses
present
from
results
Although
mechanism
tion
tests
and
certainly
is
air
the
reached.
was
avoided
PRP was not factor in the
but due to the precautions seem to be other influencing
3), there
of
aggregation
since
platelet
aggregability this
conducted more
rebound during
temporal
pattern
phenomenon
be
constant
and
late
As of
stated
tests to is
taken
and
factors
suggested in
in
platelet
by
performed
vitro
and
be
(6),
Mannucci
3 hr
the
less
who
in
aggregation
in
after vitro,
consequently,
will
aggregability,
within
markedly
after
known,
in
be
decreases
baseline
not
period
change all
should
aggregability
returned
this
variable.
similar held
indicate
venepuncture
time.
the
Escaping until
covered
be
AGGREGATIOS
(13,17).
involved
90
(14,lS). alkalinity
measured the
PLATELET
aggregation
this al
DOG
aggrega
meaningful
reported
vitro
time
a should
investigations.
IO -
a :
g 8-
L
0
7-
z
6
Q
5’
a c3
4-
0 “0
3-
I
* I -
L’l”““““““““““’ 30
0
60
90
120 AFTER
MINUTES
(ADP)
of
time
required
to
after
venepuncture
produce
on
the
amount
the standard aggregation The 4 curves depict minimal venepuncture concentrations
for
was
the
aggregation
In
vitro
sufficient
temperatures.
to
produce
Platelet
210
240
VENEPUNCTURE
and Methods Sect ion). determined every IO min after ranged from I to 10 ug (final not
180
5
FIG. influence
150
standard
aggregability
of
of
adenosine
response effective
PRP from 4 to 40
in
diphosphate (See Materials doses of ADP
4 dogs. Doses of ADP uM). alO ug of ADP response.
the
dog
was
influenced
by
03 DOG
VOl.8,SO.4
short
term
storage
concentrated temperature
on
(18)
stronger
after
ture.
This
induced than
of
after
at is
very
similar
was
markedly
tures
at
body
found
in
the
after
storage
In
and
view
factor platelet
The agent
must
be
son
of
amount is
of
ADP
are
in
decreased
assure Aqqreqat
uM EPI;
volume
to
to
human
time reached
21
ADP
in
of
EPI
dogs
in
was
Extreme
taken
released
was the
of
can
be
ADP
The also range
be
it
the
can
cause
relationship found to be of platelet
Although measured yields
at
low
when were
whole
to
to
have
tempera-
optimal is
analysis
the
21
a
of
series
(23).
of
the
findings and
that PRP as
the the
uM of
was
response
in mean experiments platelet platelet Born
and
during
aggrega-
Cross
is
(21)
density
withdrawal
PRP.
and
PRP optical recording
and
(16).
concentration
and
aggregation
response
was no chang in aggregabi lo4 - 65 x 10 2 /ul). O’Brien reactivity as a function
independent
high concentrations obtained in this
com-
This using
may be used to shown for human
aggregation
platelet method.
30
platelet 2-4). when
optical
the
to
with
rich plasma concentration.
PRP baseline
uM of
biphasic
platelet
in
30
average,
obtained
If erythrocytes are lysed the resulting in a false PRP baseline
(8 x
vs
the
and of
typical aggregaof complete
affected
there
doses
result
amplitude of (See Figs.
the aggregometer Zucker (22) has
microhemolysis
comparilow
37oC
ADP on
The curve
uM EPI
of the
at
proved,
uM EPI.
30
of
when
care be taken to agent is added.
monophasic to
aggregatif
adenosine diphosphate final concentrations (21
30
the
that,
aggregometer
uM ADP
than
count
avoid
before
shown
molarities
response
between platelet linear. Thus, concentration
aggregability
the
controlled
(5 ug) of used, the
EPI,
platelets
suggested of dog
blood
greatly
(20) in
in of
platelet is count
al
photodensity plasma reflects
also unable to find differences numbers using the optical density
easily platelet
were
aggregability
aggregated
strictly
a maximal monophasic by the differences
similar
the
centrifugation
while
aggregometer and
a steep-sloped
the
The poor
the
weights ml) were
common
Rarely was is reflected and
must
dog
most
Since are 1 inearly related, determine the platelet
density
and
EPI
temperature other hand,
responses
37oC,
They also suggest that before the aggregating
differed
uM ADP was
plasma.
care
et
37OC
molarity
the
in
intervals
Although equal of PRP (0.5
Platelet concentration. pared with the platelet observation
stored
consistent
Praga
agents
fact
remains
kept
made.
aggregator
this
PRP be
higher
while Fig. I).
responses
the
aggregation.
the
response
aggregation or
tempera-
desired.
be
aggregating
aggregation, tion (See
where
temperature
PRP has
Despite
tion
to
aqents.
a stronger
also).
20°C
were
dog
as
time
platelet
per
two
EPI).
at
platelets
increasing
the
inq
platelets
body
results,
should
used,
epinephrine these
of are
that
O°C,
ADP-induced
was
at
at room On the
less
storage Con-
term
is
added
curves
of
the
I hr
for
(and
that
in
of
of
platelets
storage
results
storage
temperature
rabbit
after
present
after
human
of
than
room temperature is recommended storage of PRP. storage Obviously, controlled if comparative or quantitative
short
aggregation
ing
the
Use
aggregation. a similar effect was not investigated.
aggregation
to
when
these
for
which
revealed but this
OOC).
of
temperature
EPI-induced
temperature
stronger
inhibited
(IOOC
room
similar
was
storage
for have
ADP-induced
storage
(19)
might
439
AGGREGATIOX
aggregation,
that
finding
only
ADP
ADP- induced found
aggregation
O’Brien
be
temperature
solutions
stantine
PLATELET
of study
of
PRP concentration,
platelets using the
it
I ity
within
(7) of
is
are available. method of variable
was platelet
most High
OX DOG
4jO
centrifugation
time
richer
in
However
,
yield,
requires
less
may time
at
temperature
both
optimal
rapidly run
The and
This H.T.S. Heart
it
Jo
work
was
stored
be
carefully
thank
consistently this
method.
variabi
1 ity
this
method
since
be
W.
Dorothy
Ansten,
and
in
Heart
related storage
to
as
if
It PRP
M.D.
gave
by
for
Barbara
the
Latta
his
prepared
critical
and
review
David
Warner,
assistance.
Brain
Grant
and
suggested
(20°C-230C)
Blouin,
valuable
Association
the time
is
is
at room temperature venepuncture.
Hampton,
as
storage
the
to
PRP concen-
well
controlled.
obtained
Hall
supported
prerequisite
aggregometer,
aggregability,
Grady,
John
the
directly
plasma and
stored min from
is
using
influence
will
James
Hodge,
of
selected
90
Oklahoma
Research
may
described,
partially
5351-14,
PRP,
concentratration is
duration
is
to
Ann
of
necessary
aggregability response
the
within
wish
even
PRP sample
responses
Louise
Jessup,
of
since
aggregometer
authors
amounts
always obtained with time, despite greater
and
platelet
aggregation
techniques
ass istance.
Janet
of
should
the
the
preferable
the
aggregation
by in
be
of
which
were
attention.
Furthermore,
temperature
Required
blood,
knowledge
amplitude
ion.
that
and
AGGREGATIOX
centrifugation
often
comparison
the
trat
above.
whole
a constant
conclusion,
meaningful since
than
of
platelet
In
described
platelets use
PLATELET
Research
Fund,
OHA G69-82,
Gold
USPHS Fami ly
Fund. REFERENCES
1.
BORN,
2.
Quantitative
G.V.R. J.
platelets. BROCK,
W.E.,
R.G.
hemophilia: 3.
4.
5.
6
7.
8.
and
attempts
the
VI I
by
F. 26.
BUCKNER,
R.G. in
at
Congress
Ala
and
of
the
K.W.E.
MACMILLAN, in man and
D.C. and laboratory
new
therapy. World
Factors O’BRIEN, J.R. Acta Med. Stand. Suppl. What de GAETANO, G. measure? Discussion.
does
of
A
the
the
blood
WULZ. 76,
464,
Canine 1963.
optical
Tehran,
plasma
1971,
levels
of
of
edited No.
252,
factor
1967. study
Suppl.
ia,
of
platelet
aggregation
Haemorrh.
aggregation 525,
55,
platelet
24, test
385,
1970.
actually
1971. aggregation
test.
1971.
optical
Med.
C.E.
Medica,
Diathes.
platelet
Stand. the
43,
525,
on
comparative
optical
Med.
and Pathol.
Haemophil
124,
Thrombos.
of
MILLER, and J.S. MAYES. of factor VIII synthesis, Proceedings Haemoph (1 ia.
Excerpta
influence
influencing
Acta
In:
212,
aggregation
BIRD, Arch.
L.R. site
Amsterdam.
Acta
does
R.M.
Federation
A.K. SIM. animals.
the
1962.
colony.
C.G. GUNN, Genetics,
Denson.
What P.M. Discussion.
67,
HAMPTON, a
CNS J.W. HAMPTON. Amer. J. Physiol.
and
I,
BUCKNER, beagles:
into
162,
J.W. of
experimental
GUNN, C.G. VIII activity.
MANNUCC measure?
London.
Establishment
HAMPTON, J.W., Canine hemophilia
p.
investigations
Physiol.,
Stand.
platelet Suppl.
aggregation 525,
60,
test 1971.
actually
OX
vo1.8,xo.4
9.
BRECHER,
G.
and
platelets. 10.
HAK,
J.
WINER,
GOLDENFARB,
15.
17.
18.
reaction
ROGERS,
The
A.B.
DAY, from
and
human
ROSSI,
effect
Holt,
Experimental
G.R.
human
blood
Rinehart
and
New York:
Design.
COOPER. The determination Atherosclerosis.
normal
of
men.
A.S. DOUGLAS. interval after
ADP-
335,
12,
1970.
The relationship venepuncture.
133, 1974.
31, inhibitors,
contact
platelets.
Thrombos.
E.C.
and
G.
platelet-rich
J.R.
Platelet
study.
PRAGA, C.A. aggregation:
and
other
variables
Diathes.
in
Haemorrh.
the 28,
29,
ZUCKER,
HASLAM, erythrocytes diphosphate
Tests
R.J.
and
of Suppl.
D.C.B.
and platelets in plasma.
separating
in
the
Clin.
Med.
and the aggregation 205, 1075, 1965.
of
rabbit
Part
I I:
15, 452, Effect
of
studying
platelets
33, 648,
increase J.
by
Some
1975.
responsiveness
85, 300,
1975.
platelets
results
from
by
a new
1962.
temperature
on
ADP-induced
anti-aggregating
platelet
drugs.
Thrombos.
183, 1973.
22.
Haemorrh.
for
Haemorrh.
dependent
in
BORN, G.V.R. and M.J. CROSS. London. 168, 178, 1963. M.B.
Methods
induced
139, 1100, 1972.
Med.
Lab.
POGLIANI.
21.
Diathes.
time
aggregation
Biol.
ZUCKER. Diathes.
Pathol.
significance
Haemorrh.
platelet
epinephrine.
Cl in.
E.M. Its
human Exptl.
aggregation,
J.
and
to
Temperature Nature.
diphosphate.
of
A
LOUIS.
J.W.
pH on Sot.
and M.B. Thrombos.
plasma
CONSTANTINE,
O’BRIEN,
of Proc.
ADP.
H. HOLMSEN, and plasma.
H.J., blood
Diathes.
23.
of
1972.
method
20.
Haemorrh.
of
and
OGSTON, and and time
Proteolytic
M.B.
release
adenosine
19.
New York:
in
in
CORINA, D. aggregation
Diathes.
ZUCKER,
of
CATHEY,
aggregation
A. C., platelet
epinephrine
16.
Psychologists.
Principles
M.H.
P.B.,
platelet
WARLOW, between
393,
for
enumeration
1950.
1962.
11.
Thrombos. 14.
and
3, 365,
Physiol.
‘iJ 1
AGGREGXTIOK
Morphology
CRONKITE.
Statistical
B.J.
induced 13.
PLATELET
1966.
McGraw-Hi 12.
E.P. Appl.
Statistics
W.L.
Winston. 11.
DOG
The
platelet 42, MILLS.
aggregation
adhesion, 1,
of
blood
J.
platelets.
aggregation
and
release.
1970. The
in relation Biochem. J.
adenylate to
kinase the
103, 773,
of
degradation
1967.
human of
plasma, adenosine
Physiol.,
Thrombos.